Acutissimmin |
|
Ethanol-induced ulcers/Intragastric/50.0 mg/kg |
Mouse |
Active |
[82] |
Agrimoniin |
|
Helicobacter pylori-MIC (25 μg/mL) |
In vitro |
Active |
[92] |
Alienanin B |
|
Helicbacter pylori-MIC (25 μg/mL) |
In vitro |
Active |
[92,93] |
Chlorogenic acid |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,94] |
|
Castalagin |
|
Ethanol-induced ulcers/Intragastric/50.0 mg/kg |
Mouse |
Active |
[82,95] |
Casuarictin |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,96] |
Casuarinin |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,97] |
Corilagin |
|
Helicobacter pylori-MIC (6.25 μg/mL) |
In vitro |
Active |
[92,98] |
8-CRHA-Glc naringenin |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,99] |
Elaeagnatin A |
|
Helicobacter pylori-MIC (25 μg/mL) |
In vitro |
Active |
[92,100] |
Elagic acid |
|
Stress-induced ulcers(water immersion)/intraperitoneal/5, 10 and 25 mg/kg |
Rat |
Active |
[90,101] |
|
|
Pylorus-ligated animals/Intraperitoneal/5, 10 and 25 mg/kg |
Rat |
Active |
[90,101] |
|
|
Inhibition of gastric H+, K+-ATPase |
Hog gastric mucosal |
Active |
[90,101] |
Epicatechin |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,102] |
Epicatechin gallate |
|
Helicobacter pylori-MIC (50 μg/mL) |
In vitro |
Active (Less) |
[92,102] |
Epigallocatechin gallate |
|
Helicobacter pylori-MIC (25 μg/mL) |
In vitro |
Active |
[92,102] |
Geraniin |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92] |
|
|
Stress induced ulcer |
Mouse |
Active |
[92,103] |
Heterophylliin G |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,104] |
Hippophenin A |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,100] |
Iridin |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,105] |
Isorhamnetin 3-O-rutinoside
|
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,106] |
Nobotanin B |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,96] |
Oenothein A |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92] |
Oenothein B |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,107] |
Pedunculagin |
|
Ethanol-induced ulcers/Intragastric/50.0 mg/kg |
Mouse |
Active |
[82,108] |
Penta-O-galloyl-β-d-glucose
|
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92,109] |
Phillyraeoidin A |
|
Ethanol-induced ulcers/Intragastric/50.0 mg/kg |
Mouse |
Active |
[82,110] |
|
Procyanidin B1 |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,111] |
Procyanidin B3 |
|
Helicobacter pylori-MIC (50 μg/mL) |
In vitro |
Minimal activity |
[92,111] |
Procyanidin B4 |
|
Helicobacter pylori-MIC (50 μg/mL) |
In vitro |
Minimal activity |
[92,111] |
Procyanidin B5 |
|
Helicobacter pylori-MIC (25 μg/mL) |
In vitro |
active |
[92,112] |
Procyanidin C1 |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,113] |
Procyanidin polymer |
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,99] |
Rugosin D |
|
Helicobacter pylori-MIC (25 μg/mL) |
In vitro |
Active |
[92] |
Strictinin |
|
Helicobacter pylori-MIC (6.25 μg/mL) |
In vitro |
Active |
[114] |
Tannic acid |
|
Shay ulcer/oral/50.0 mg/kg |
Rat |
Active |
[115,116] |
|
|
Acetic acid-induced ulcer/oral/200.0 mg/kg |
Rat |
Active |
[116] |
|
|
Pylorus-ligated animals/oral/50.0, 100.0 and 500 mg/kg |
Rat |
Active |
[116] |
|
|
Ethanol induced gastric lesions/gastric intubation/100.0 mg/kg |
Rat |
Active |
[117] |
|
|
Inhibition of gastric H+, K+-ATPase |
Hog gastric mucosal |
Active |
[118] |
Tellimagrandin I |
|
Helicobacter pylori-MIC (12.5 μg/mL) |
In vitro |
Active |
[92] |
|
Tellimagrandin II |
|
Helicobacter pylori-MIC (6.25 μg/mL) |
In vitro |
Active |
[92] |
Tri-N-coumaroyl-spermidine
|
|
Helicobacter pylori-MIC (>100 μg/mL) |
In vitro |
Inactive |
[92,118] |